Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.

Sullivan lawyers use sound business judgment to counsel emerging companies on a full range of business and legal issues. We balance business needs and legal realities to help growing companies thrive.

We counsel emerging companies in connection with protecting valuable intellectual property, securing equity and debt financing, negotiating technology licenses and joint ventures, mergers and acquisitions, crafting tax and deferred compensation strategies, resolving employment issues and responding to the threat of litigation. Our lawyers understand the opportunities our clients need to take advantage of and provide quality, cost-effective solutions that help emerging companies cope with the human and financial challenges of rapid growth.

Our entrepreneurial clients often enter transactions with much larger enterprises, many of which are represented by large law firms. Through our extensive deal experience, we enable our clients to negotiate on a level playing field. Our strong commitment to best-in-class client service ensures we provide effective representation regardless of the complexity of the matter at hand. 

Israel

In today’s fast-changing business world, clients value a global outlook as much as global experience. We work with many Israeli technology companies in all stages of development and are committed to the success of Israeli and U.S. companies seeking to do business in each other's countries. We help global companies tap the capital markets, complete M&A transactions and seek investors through attorneys in our Tel Aviv office, as well as our U.S. offices. We leverage our experience on both sides of the Atlantic to help clients advance their objectives with maximum efficiency—whether it's raising venture capital, negotiating an M&A transaction, forming a joint venture or listing a company on Nasdaq.

We represent numerous international funds and family offices in their investment into Israeli start up companies. We also act as underwriter’s counsel in public offerings of both U.S. and Israeli companies traded on Nasdaq or the NYSE. But we do more than just provide legal services; we build business bridges for our clients, connecting them with the right players and the right resources to gain a competitive edge. With locations in the U.S., Israel and the United Kingdom, we provide completely integrated, cost-efficient legal services.

Emerging Companies

Drawing on business acumen based on years of experience and countless transactions, our attorneys understand an emerging growth company’s business needs and constraints, and act as partners in growth with our clients. Entrepreneurs look to us for sound business advice. We know the issues that may arise and pass along the benefit of this experience to our emerging company clients. Whether the issue involves structuring advice on a financing, a potential strategic alliance, a thorny tax issue, a problem with stock options, a recalcitrant ex-employee, the threat of litigation or a liquidity event, we have been there before.

We are seeking long-term partnerships with our clients and can advise them along the way as they mature. We have helped companies grow at every phase, from start-up to profitability to public company. Whether through a merger, acquisition, or initial public offering, we have helped many successful clients realize the fruits of their labors. We have represented clients in mergers, acquisitions, and consolidations, both public and private, in transactions valued at less than a million dollars to greater than $10 billion, and we have guided clients, both domestic and foreign, through initial public offerings and follow-on offerings on all of the major stock exchanges.

Our representation of start-up businesses includes reviewing business plans and meeting with founders; identifying and introducing financing sources, collaboration partners, qualified candidates for management positions and outside consultants; mediating and documenting relationships among founders; structuring the transfer and protection of intellectual property; providing guidance on the formation of an effective board of directors, as well as strategic advice at board meetings; and advising on the establishment of equity incentives. As our clients mature, we help negotiate licenses of intellectual property; document joint ventures, alliances, and other relationships; lease real estate and equipment; assist with wealth and estate planning; resolve disputes; counsel on growth by acquisition strategies and advise on all types of financing strategies and liquidity events, including Regulation D and Regulation S private placements, PIPEs and public offerings.

Representative Client Work

  • Represented Impact Analytics, an artificial intelligence company, in its $11 million growth financing led by Argentum Capital Partners IV, L.P.
  • Represented Nano Dimension (Nasdaq: NNDM), an industrial 3D printer, in its $70 million acquisition of DeepCube Ltd. and its over $54 million acquisition of NanoFabrica Ltd.
  • Represented KUDO, the cloud-based video conferencing platform with real-time multilingual interpretation in 100+ languages and 147 sign languages, on its $21 million Series A Preferred Stock financing
  • Represented Somatix, a digital health company focused on remote patient monitoring, in connection with its Series A financing, convertible notes offering and day-to-day matters
  • Represented Rescue Hearing, a gene therapy company, in connection with its license to Myrtelle Inc. to develop a novel gene therapy for hearing loss
  • Represented DarioHealth (Nasdaq: DRIO), a digital therapeutics company, in connection with its $30 million acquisition of PsyInnovations, Inc., dba wayForward, a behavioral health digital platform
  • Represented Clear Genetics, a software company focused on integrating genetics into routine patient care, in connection with its $50 million acquisition by Invitae Corporation (NYSE: NVTA)
  • Represented a privately held fiber optics and wireless communication sub-component manufacturer when it was acquired by a publicly traded company for $77 million
  • Represented a privately held communications company when it was acquired by a publicly traded corporation for aggregate consideration of $175 million
  • Secured complex source code cross-licensing arrangements for a developer of software used in the commercial real estate market
  • Represented an Australian engineering software development company in a dispute concerning the theft of confidential, proprietary and trade secret information
  • Facilitated a telecommunications company's IPO and counseled on other offerings of equity and debt securities valued at more than $5 billion
  • Helped an Israeli smart-card technology company successfully challenge a government award decision in the Electronic Passport program
  • Provided international and domestic tax counsel to the leading global developer of product lifecycle management (PLM) solutions
  • Represented venture-backed parallel file system software company in financing rounds totaling more than $30 million and in negotiating multi-million dollar OEM, licensing and distribution transactions
  • Represented software company in the multi-million dollar sale of its U.S., Irish and U.K. assets and shares to a publicly traded Israeli company
  • Represented developer of polymer photovoltaic products in its $18 million Series C round of financing
  • Represented a leading provider of AI-driven SaaS solutions for planning and merchandising within the retail industry, in an $11m growth financing

Venture Capital

We represent regional, national, and international venture capital firms, family offices and Angel and other investors that invest in early-stage companies across a range of industries, most notably in software, telecommunications, therapeutics, medical devices and fintech. We help these investors deal with the many contingencies that arise in transactions such as portfolio investments, liquidity events, corporate governance and compliance matters, intellectual property and other due diligence-review services and assessments of complex patent portfolios and strategy. We also work with venture capital firms on fund formation and fund-raising efforts, and regularly advise institutions making investments in venture capital funds. We have negotiated investment terms with scores of venture capital firms around the world. A key strength is our ability to facilitate introductions between investors and entrepreneurs and emerging companies, particularly for technology companies founded in Israel and Ireland.

Representative Client Work

  • Represented a Massachusetts-focused seed and early-stage venture firm in numerous portfolio company investments in the software, communications, life sciences and material sciences sectors
  • Assisted major financial services firm in strategic venture investments of more than $225 million in international telecommunications companies
  • Represented 97212 Ventures and ICONYC labs, accelerators focused on supporting Israeli tech companies expanding to the United States, in connection with formation and financing matters
  • Represented family offices in connection with their investments in venture funds, start-up companies and real estate
  • Represented a group of venture capital investors in financing rounds aggregating $21.5 million in early-stage funding for a medical technology company developing an innovative, percutaneous approach for delivering heart valves to treat late-stage aortic stenosis
  • Represented a leading venture capital fund with more than $1.6 billion in committed capital under management; facilitated the fund's first "going-private" transaction with a publicly traded enterprise
  • Represented a venture capital firm in connection with due diligence analyses related to a number of medical device technologies, including spinal implants, ocular lens implants, vascular grafts, aortic valve replacements and cardiac ablation devices
  • Represented a syndicate of life sciences venture capital firms in a series of multi-million dollar bridge financings followed by a $4.4 million financing round and recapitalization for a developer of disposable catheter products for the treatment of cardiovascular disorders using laser energy

Viewpoints
All Viewpoints
FINRA’s Small-Cap Sweep: Strategic Steps for Broker-Dealers
It has been approximately one (1) month since the Financial Industry Regulatory Authority (FINRA) has launched a targeted review of broker-dealer activity in small-capitalization offerings involving foreign issuers—particularly those with operations in foreign jurisdictions such as China. The scope of the review extends across both public and private offerings of small-cap exchange-listed issuers and applies to firms that have acted as underwriters, bookrunners, syndicate or selling-group members, placement agents, or engaged in follow-on trading or omnibus account activity. For broker-dealers active in this market segment between January 1, 2023, and September 30, 2025, this initiative warrants immediate attention. FINRA’s focus underscores the need for firms to proactively strengthen compliance, supervisory and due-diligence frameworks before scrutiny is initiated. Implications for Broker-Dealers For broker-dealers that have acted in offerings of foreign-issuer small-cap companies, or engaged in corresponding trading, the risk of regulatory inquiry is now heightened. Firms should assume that FINRA may request detailed documentation of supervisory procedures, training materials, due-diligence records, compensation arrangements, and transaction lists. Potential exposure encompasses both the underwriting/placement side and the secondary trading side, particularly where omnibus accounts or affiliate-linked trading have occurred. Moreover, compliance weaknesses in this area may expose firms to broader regulatory focus given FINRA’s emphasis on market integrity and manipulative trading risks in small-cap IPOs. As a result, firms should view this not simply as a matter of historical transactions but as an active compliance priority for present-day operations and future offerings. Strategic Compliance Priorities and Action Plan Broker-dealers should undertake an immediate, firm-wide review of their involvement in relevant small-cap foreign-issuer offerings. This review should begin with an inventory of all transactions, public or private, in which the firm acted as underwriter, bookrunner, syndicate or selling-group member, placement agent, or participated in secondary trading during the relevant period. Firms should review whether their written supervisory procedures (WSPs), compliance manuals, training materials and internal guidance adequately address the risks particular to small-cap foreign-issuer offerings. This includes controls around due diligence of issuers, audit-firm and management backgrounds, beneficial-owner structures, cross-border legal/regulatory risks, syndicate compensation, and trading after the offering. Surveillance systems and trading desk controls should similarly be assessed to ensure they capture unusual trading patterns consistent with manipulative or coordinated activity. Firms should evaluate whether their AML/KYC programs are appropriately scaled to the enhanced risk of foreign issuers and thinly-traded securities, and whether their vendor-risk frameworks adequately cover third-party trading platforms, omnibus accounts, and algorithmic or remote trading tools. From a governance standpoint, senior management, compliance heads and the board should elevate this matter within their risk-assessment frameworks. Firms should consider whether internal audit scopes and independent reviews cover this business line, whether incentives or compensation structures may have encouraged participation in higher-risk offerings, and whether escalation procedures are clearly defined and monitored. Finally, firms should prepare for regulatory engagement by gathering and organizing deal files, training logs, supervisory review documentation, compensation records and transaction lists now, rather than waiting until a request arrives. Key Takeaways The targeted review by FINRA of small-cap foreign-issuer offerings signals a clear regulatory priority and a call to broker-dealers to raise their vigilance. For firms with exposure in this area, now is the time to act. Waiting until after a request is received may leave a firm scrambling and vulnerable to findings of deficient controls or documentation. The themes underpinning the review—cross-border risk, thin-traded securities, manipulative activity, and weak controls—are broader than the specific focus and should prompt firms to proactively enhance controls across the board. Senior leadership should not view this as a niche compliance issue, but rather as a signal of elevated scrutiny across multiple lines of business. With proper preparation, firms can not only respond to potential regulatory requests but demonstrate a thoughtful, forward-looking compliance program aligned with the evolving risk landscape.
FINRA Launches Targeted Review of Small-Cap Foreign Offerings
The Financial Industry Regulatory Authority (FINRA) has announced a targeted review of broker-dealers involved in small-cap initial public offerings (IPOs) and related transactions for companies based in foreign jurisdictions, such as China. The review signals increased regulatory scrutiny of potential stock manipulation risks, cross-border due diligence practices and overall compliance controls within the small-cap market, which includes broker-dealers and ultimately issuers whose stock trades on U.S. exchanges. Overview FINRA’s latest initiative underscores the regulator’s focus on potential market-abuse risks tied to foreign small-cap listings. While FINRA has not specified the impetus for the sweep, the timing aligns with publicly announced emphases on cross-border enforcement efforts. The SEC, which oversees FINRA, announced in September the formation of a task force to combat cross-border fraud and securities-law violations in jurisdictions “where governmental control and other factors pose unique investor risks,” explicitly citing China. Earlier this year, Nasdaq proposed increasing the threshold size of IPOs for Chinese companies, including issuers based in Hong Kong and Macau, to $25 million, versus $15 million for other issuers. According to FINRA, the review targets member firms that participated in multiple small-cap offerings, defined as IPOs raising $25 million or less and priced between $4.00 and $8.00, between January 2023 and September 2025. The inquiry also extends to follow-on offerings and private placements linked to those transactions. Focus Areas FINRA has requested detailed information from firms that served as underwriters, bookrunners, syndicate members, selling group members, or placement agents in the identified offerings. The regulator is seeking documentation that addresses: Due diligence, insider trading and anti-money-laundering (AML) compliance policies, including internal training materials; Supervisory procedures related to cross-border offerings and compliance with SEC Regulation M and FINRA Rule 5210; and Comprehensive transaction records, including all professional participants (e.g., auditors, legal counsel and internal approvers). FINRA’s emphasis on documentation, deal structure and related-party identification indicates a broader assessment of firms’ governance and risk-management frameworks around small-cap and foreign issuer activity. Takeaways for Broker-Dealers Firms active in small-cap or foreign offerings should take immediate steps to assess their exposure and confirm the effectiveness of their compliance controls. Recommended actions include: Reviewing recent and pending small-cap transactions to determine whether they fall within FINRA’s stated parameters. Evaluating supervisory systems, due diligence processes and deal-approval workflows for coverage of cross-border risks and compliance with Regulation M and FINRA Rule 5210. Reviewing annual AML testing results to ensure trading surveillance programs, including alert thresholds, omnibus account oversight and escalation protocols, are effectively in place and reasonably designed to identify and address red flags. Preparing responsive documentation proactively to facilitate timely engagement with FINRA if contacted. Looking Ahead FINRA’s targeted review is part of a broader regulatory trend emphasizing cross-border transparency and control effectiveness. Firms with recurring involvement in small-cap or foreign offerings should anticipate heightened scrutiny from both FINRA and the SEC and ensure that their regulatory and compliance frameworks align with evolving expectations. Sullivan’s Small-Firm Task Force is advising clients on responding to FINRA requests and enhancing compliance programs to withstand heightened scrutiny in this area. The Task Force, comprised of lawyers from the firm’s transactional capital markets, regulatory compliance, and white collar/government investigations practice groups, will use its multidisciplinary approach to defend these inquiries and cost-effectively advance the agenda and priorities of the constituencies impacted by the evolving regulatory focus on targeted inquiries in the small-cap market.
Sullivan & Worcester Continues Expansion of London Platform with Arrival of 10-Attorney Award-Winning Emerging Companies and Venture Capital Team
June 25, 2026 – International law firm Sullivan & Worcester (Sullivan) today announced the arrival of one of the UK’s leading Emerging Companies and Venture Capital teams, significantly enhancing the firm's transatlantic capabilities and accelerating its strategic growth in London. The team, which was recently recognized as Growth Capital Team of the Year at the 2026 The Lawyer Awards in London, is led by partners James Shaw, Iain Cockburn and Ben Williams, who are joined by counsels Mary Harley, Tina Baker and Andrew Gay, and associates Yeji Lee, Francesca Salisbury, Fai Tai, and Ali Woodcock-West, and two dedicated business support professionals. Their arrival establishes a premier Emerging Companies and Venture Capital practice in London, further advancing Sullivan’s strategy of building a fully integrated international platform serving innovative, high-growth businesses and the investors that back them. The team advises venture-backed companies, founders, and investors across the full business lifecycle, including venture financings, mergers and acquisitions, intellectual property strategy, and complex strategic advisory matters. “This is a transformational addition to our already strong London office and a major milestone in the continued expansion of our international platform,” said David Nagle, Sullivan’s Managing Partner. “James, Iain, Ben, and their team are widely recognized as leaders in the emerging companies and venture capital market, with deep relationships across the innovation economy and a proven track record advising businesses from formation through to successful exits and access to U.S. capital markets. Their arrival significantly enhances our ability to serve founders, investors, and growth companies on both sides of the Atlantic. We are delighted to welcome them to the firm.” The group has developed a market-leading reputation across some of the world’s most dynamic sectors, including life sciences, climate technology, fintech, deeptech, and artificial intelligence. Shaw, who leads the team joining Sullivan, said, “We are excited to join a firm with such a powerful U.S. platform and deep international finance capabilities. As innovation-driven companies increasingly operate across borders and look to access U.S. markets and capital, the opportunity to combine our practice with Sullivan’s global reach creates a compelling proposition for founders, investors, and emerging businesses. We look forward to collaborating with our new colleagues and continuing to support clients through every stage of growth.” The team joins Sullivan’s highly regarded London office, which has experienced significant momentum in recent years. The firm's market-leading trade and export finance practice, led by Geoffrey Wynne, was further strengthened in 2025 with the additions of partners Robert Parson and Matthew Cox, enhancing Sullivan’s position as a leading advisor on complex cross-border transactions and financing matters. PARTNER BIOS James Shaw – James advises entrepreneurs, emerging growth companies and investors across all stages of the corporate lifecycle. With more than 20 years of experience, he is trusted counsel to founders and investors, and frequently serves as outside general counsel to science-based and innovative companies. Highly regarded for his work in the European life science and fintech sectors, he has extensive experience representing companies on complex corporate transactions, venture capital financings, strategic investments, acquisitions, and divestitures. Iain Cockburn – Iain advises founder and management-led high-growth companies, as well as venture capital funds and institutional investors, on significant venture and growth transactions. His work includes later-stage financings, pre-exit rounds, lead investor mandates, consortium investments, secondary transactions and cross-border matters. Iain also advises on the broader corporate issues that arise as companies scale and institutionalize, including governance arrangements, investor rights, founder and management equity structures, shareholder arrangements, strategic corporate matters, as well as issues relating to the UK’s National Security and Investment Act 2021. Ben Williams – Ben is a leading commercial technology lawyer advising innovative growth companies (including unicorns and decacorns) and their investors. He supports high-growth businesses and investors in developing, deploying and scaling technology products globally, leading complex cross-border commercial negotiations. With strong transatlantic expertise, he aligns technology, regulatory and tax frameworks across jurisdictions. Ben also advises on AI, data, national security and emerging regulation, delivering pragmatic, commercially focused solutions that enable innovation while managing risk. About Sullivan Sullivan & Worcester (Sullivan) is a premier, AmLaw 200 international law firm with lawyers in Boston, London, New York, Tel Aviv and Washington, D.C. Sullivan’s clients, including Fortune 500 companies, leading financial services firms and asset managers, boards of directors, real estate companies, and emerging businesses, rely on Sullivan’s ability to navigate complex legal and operational landscapes, the impeccable judgment of its lawyers, and its commitment to best-in-class client service.
Top Tier Firm, Legal 500 United States 2026
Sullivan & Worcester Ranked in the Legal 500 United States 2026 Edition
Boston, MA – Sullivan & Worcester announced that its practice groups and attorneys have been ranked and recommended in the Legal 500 United States 2026. The firm’s Real Estate practice was newly ranked Tier 1 in the “Real estate – mid-market ($0-500m)” category and the firm maintained rankings across a variety of practice areas. Partners Nicole Crum and John Steiner were newly ranked as Leading Partners and Ryan Rosenblatt as a Next Generation Partner. Peers and more than 300,000 corporate counsel were surveyed and interviewed globally in the past 12 months to assess law firms’ overall visibility and reputation, culminating in detailed rankings and editorial. The Legal 500 is an independent guide, and firms and individuals are recommended purely on merit. Sullivan's lawyers received the following rankings: Leading Partners: The Legal 500’s Guide to Outstanding Lawyers Nationwide Benjamin Armour - M&A: Middle-Market (Sub-$500m); M&A: middle-market ($0-250m) Ameek Ashok Ponda - Real Estate Investment Trusts (REITs)  Nicole Crum - Mutual/registered/exchange-traded funds Lewis Segall - M&A: Middle-Market (Sub-$500m); M&A: middle-market ($0-250m) John Steiner - Real estate – mid-market ($0-500m) Douglas Stransky - International Tax Joel Telpner - Fintech Next Generation Partners: The Legal 500’s Guide to Up-and-Coming Lawyers Nationwide Ryan Rosenblatt - General commercial disputes – mid-market ($250-500m) Sarah Wellings - Real Estate Investment Trusts (REITs) Practice Areas Ranked and Attorneys Recognized Corporate Governance “Our lead partner, Nicole Crum, who leads the investment industry practice, is exceptional. She demonstrates strong industry knowledge yet is very personable and anticipates what we need to know or what we should consider doing to handle any matter. The team roll up their sleeves and provide recommendations as to how we as a board should handle any matter. Strong service commitment and work ethic!” “The team we have at Sullivan & Worcester has served our company for years and knows the management team, staff as well as our board members. They are extremely responsive and proactive and anticipate what we should be aware of, concerned about, excited about, and how to handle oversight, processes and protocols to ensure we are carrying out our fiduciary duties. The partners are experts in this industry.” Leading Partner: Nicole Crum Recommended Lawyers: Howard Berkenblit, David Leahy Dispute Resolution/General Commercial Disputes “Diverse skillset. Client centric. Transparency. Urgency provided on all matters.” “I have worked with Gerry Silver for over 15 years and have found his pragmatic approach to complex matters refreshing. He understands our business, culture and market, and will give me his opinion in a digestible manner.” Next Generation Partner: Ryan Rosenblatt Recommended Lawyers: Gerry Silver, Patrick Dinardo, Laura Steinberg, Michael Sullivan, Amy Zuccarello, Erika Todd, Christopher Shields, Anna Lea McNerney Employee Benefits, Executive Compensation and Retirement Plans: Design “The level of expertise is top shelf. David Guadagnoli seems to know all of ERISA and IRS rulings.” “David Guadagnoli and Amy Sheridan both have superior knowledge in their respective areas. I value the ability to raise issues whether simple or complex. The firm takes the same diligent approach across all spectrums of complexity.” Recommended Lawyers: David Guadagnoli, Amy Sheridan Environment: Transactional Fintech “Sullivan & Worcester is one of the finest firms with which I have worked.” “The lawyers are excellent, and the firm consistently provides the highest quality of customer service.” Leading Partner: Joel Telpner Recommended Lawyers: Natalie Lederman, Benjamin Armour, Scott Kaufman, Harvey Bines, Christopher Curtis Land Use/Zoning Recommended Lawyers: Gregory Sampson, Ashley Brooks, Victor Baltera, Karen Kepler, Ashley Tan M&A: Corporate and Commercial: Venture Capital and Emerging Companies Recommended Lawyers: Scott Kaufman, Lewis Segall, Benjamin Armour, Michael Student M&A: Middle-Market ($0-250m) “The partner Lewis Segall has been working with our company for 15 years and we have a good working relationship with him. He knows our history and very attentive to our needs.” “Lewis Segall is very attentive to our needs. We very much value him.” Leading Partners: Benjamin Armour, Lewis Segall Recommended Lawyers: Natalie Lederman Mutual/Registered/Exchange-Traded Funds “Sullivan & Worcester's practice is defined by its deep expertise in investment funds and its ability to deliver clear, commercially grounded advice across the full fund lifecycle—from formation and structuring to regulatory compliance and complex transactions.” “The team is highly experienced, collaborative, and excel in efficient execution and clear communication.” Leading Partner: Nicole Crum Recommended Lawyers: David Leahy, David Mahaffey, Rachael Schwartz Real Estate Leading Partner: John Steiner Recommended Lawyers: Ashley Brooks, Karen Kepler, Gregory Sampson, Sharon Leifer, Louis Monti, Spencer Stone, Ashley Tan Real Estate Investment Trusts (REITs) “We have built multiple complex and sophisticated REIT platforms over the years and worked with many top-tier REIT specialists, but Sullivan’s REIT practice is by far the best, with Sarah Wellings.” Leading Partner: Ameek Ashok Ponda Next Generation Partner: Sarah Wellings Recommended Lawyers: Angela Gomes, Louis Monti, Shu Wei, Cameron Cosby International Tax “The international collaboration with S&W is exceptional.” “What really stands out is their willingness to engage, openness to different ideas and opinions, clearly expressed expectations, and clients' objectives.” Leading Partner: Douglas Stransky Recommended Lawyers: Lewis Greenwald, Eric Rietveld Tax > US Taxes: Contentious Recommended Lawyers: Richard Jones, David Nagle, Daniel Ryan, Caroline Kupiec Tax > US Taxes: Non-Contentious “Sarah Wellings is, quite simply, the best lawyer we have ever worked with. Her expertise extends far beyond tax and REIT matters, encompassing governance, financing, and complex commercial issues. Decades of experience and technical mastery make her an indispensable partner. Sarah is our central point of contact who makes everything seamless. Her in-house counsel background gives her a unique client perspective: she anticipates needs, solves problems before they arise, and delivers concise, well-structured updates that simplify even the most intricate issues. She coordinates effortlessly with all parties involved. Her judgment is exceptional. Sarah strikes the perfect balance between comprehensive academic rigor and practical, business-oriented advice. She combines technical REIT/tax excellence with commercial instincts, ensuring every recommendation is both legally sound and strategically smart. Her ability to translate complex law into clear, actionable guidance is unmatched. Sarah is incredibly responsive without ever sacrificing quality. She treats our matters as her own, demonstrating a rare ownership mindset and collaborative spirit. Her integrity is uncompromising, giving us absolute confidence in her counsel. In short, Sarah Wellings defines legal excellence: reliable, commercially minded, and client-focused. Working with her feels like being in the safest possible hands; she consistently exceeds expectations and orchestrates complex transactions with clarity and precision.” Recommended Lawyers: Ameek Ashok Ponda, Richard Jones, Douglas Stransky, Sarah Wellings About Sullivan Sullivan & Worcester (Sullivan) is a premier international law firm with lawyers in Boston, London, New York, Tel Aviv and Washington, D.C. Sullivan’s clients, including Fortune 500 companies, leading financial services firms and asset managers, boards of directors, real estate companies, and emerging businesses, rely on Sullivan’s ability to navigate complex legal and operational landscapes, the impeccable judgment of its lawyers, and its commitment to best-in-class client service.

Emerging Companies & Venture Capital

Biotech Focused On Developing Non-Opioid Therapeutics to Alleviate Pain Announced IPO

Sullivan was issuer's counsel for Chromocell Therapeutics Corporation, a clinical-stage biotech company focused on developing and commercializing new, non-opioid therapeutics to alleviate pain, in their $6.6 million initial public offering of common stock.

The Sullivan team was led by David Danovitch, director of the firm’s Corporate Department, with partners Charles E. Chambers Jr., Aaron Schleicher and associate Brian Hurley. Sullivan has developed a strength in working with entrepreneurial biotech and tech companies in the U.S. and in Israel.

David E. Danovitch, Charles E. Chambers Jr. and Brian P. Hurley

Artificial Intelligence Company Advised in Growth Financing

Sullivan represented Impact Analytics Inc. in its $5.5 million growth financing round led by Argentum Capital Partners. The company unites artificial intelligence with human validation that brings machine learning to the forefront of data-driven business decisions.

Lewis N. Segall and Johanna Colpritt

Young businesswoman looking at smartphone in spaceship like corridor

Emerging Companies & Venture Capital

Emerging Companies & Venture Capital